Preprint
Article

Short-term Comparison of Switch to Brolucizumab or Faricimab in Eyes with Aflibercept-Resistant Neovascular AMD

This version is not peer-reviewed.

Preprints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

© 2025 MDPI (Basel, Switzerland) unless otherwise stated